Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver.
about
Hepatitis C virus non-structural protein NS3 interacts with LMP7, a component of the immunoproteasome, and affects its proteasome activityIFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient responseEthanol-induced oxidant stress modulates hepatic autophagy and proteasome activityMechanisms of HIV protein degradation into epitopes: implications for vaccine designImmunoproteasomes: structure, function, and antigen presentationVirus-induced type I IFN stimulates generation of immunoproteasomes at the site of infectionThe immunoproteasome and viral infection: a complex regulator of inflammationThe ubiquitin-proteasome systemNitric oxide-dependent CYP2B degradation is potentiated by a cytokine-regulated pathway and utilizes the immunoproteasome subunit LMP2Directional responses following recombinant cytokine stimulation of rainbow trout (Oncorhynchus mykiss) RTS-11 macrophage cells as revealed by transcriptome profiling.In vivo accumulation of Helicobacter pylori products, NOD1, ubiquitinated proteins and proteasome in a novel cytoplasmic structureImmunoproteasomes: regulating the regulator.PA28αβ: the enigmatic magic ring of the proteasome?Impact of distinct poxvirus infections on the specificities and functionalities of CD4+ T cell responsesUnexpected role for the immunoproteasome subunit LMP2 in antiviral humoral and innate immune responses.Differential expression of 26S proteasome subunits and functional activity during neonatal developmentThe proteasome system in infection: impact of β5 and LMP7 on composition, maturation and quantity of active proteasome complexesRNA-seq liver transcriptome analysis reveals an activated MHC-I pathway and an inhibited MHC-II pathway at the early stage of vaccine immunization in zebrafish.Molecular characterization and expressional affirmation of the beta proteasome subunit cluster in rock bream immune defense.Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes.Peptide-MHC-I from Endogenous Antigen Outnumber Those from Exogenous Antigen, Irrespective of APC Phenotype or Activation.Reduction in ATP levels triggers immunoproteasome activation by the 11S (PA28) regulator during early antiviral response mediated by IFNβ in mouse pancreatic β-cells.Alcohol abuse enhances neuroinflammation and impairs immune responses in an animal model of human immunodeficiency virus-1 encephalitis.Ongoing coxsackievirus myocarditis is associated with increased formation and activity of myocardial immunoproteasomesGamma interferon and perforin control the strength, but not the hierarchy, of immunodominance of an antiviral CD8+ T cell response.The ubiquitin ligase Cbl-b limits Pseudomonas aeruginosa exotoxin T-mediated virulence.Role of immunoproteasome catalytic subunits in the immune response to hepatitis B virusGeneration of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII.Hepatitis C virus mutation affects proteasomal epitope processingSubunit specific inhibitors of proteasomes and their potential for immunomodulationProteomics to display tissue repair opposing injury response to LPS-induced liver injury.The murine cardiac 26S proteasome: an organelle awaiting exploration.Memory CD8 T cells specific for plasmodia liver-stage antigens maintain protracted protection against malaria.The proteasome immunosubunit multicatalytic endopeptidase complex-like 1 is a T-cell-intrinsic factor influencing homeostatic expansionA cytomegalovirus inhibitor of gamma interferon signaling controls immunoproteasome induction.Identification of Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA2) target proteins by proteome analysis: activation of EBNA2 in conditionally immortalized B cells reflects early events after infection of primary B cells by EBV.Targeted inhibition of the immunoproteasome is a potent strategy against models of multiple myeloma that overcomes resistance to conventional drugs and nonspecific proteasome inhibitorsHuman immunodeficiency virus type 1 Gag p24 alters the composition of immunoproteasomes and affects antigen presentation.Expression of immunoproteasome genes is regulated by cell-intrinsic and -extrinsic factors in human cancersDifferential expression of constitutive and inducible proteasome subunits in human monocyte-derived DC differentiated in the presence of IFN-alpha or IL-4.
P2860
Q24300867-8962F3BC-A35C-4913-BEBB-FADDDC903E6EQ24531439-6FE3BA85-7F48-4199-BD16-9E8672B53536Q26852284-61519CA3-362E-4519-A1CF-30D2A84C0D2DQ26866505-5149D43A-7EA5-48B5-AA7D-770F24E8D530Q27024527-E2CFDCEE-B8FD-4BF5-8918-1F2D0E35A83FQ27477499-B0EDDFFA-7FC7-4983-ADCA-CE07A6ADB1E5Q27694656-4E0A57E3-2845-4CF1-80DC-4C6FE88134DFQ28305844-CE906326-624D-4650-8AEB-9AD2571C4485Q28584243-306B90FA-F15A-4ED5-9600-1616245725BCQ33287047-6E6C2B59-439C-4365-80EE-88E295EBFB35Q33543097-A685E548-EC34-4A41-ADED-78E86735020AQ33879127-421700BA-121D-4402-B1CE-16DCD4B022A2Q33912635-CD4B547B-63B1-4CA3-A4D4-748B45C6674DQ34059488-6AD10055-F2F5-4D63-A28A-9ABEA6E4F4D0Q34135115-39C97297-E0D4-43EE-BD1F-624ACF3C76CDQ34318189-2590C214-09E4-464F-ACFF-F1C271970A93Q34328313-3C04B105-7ACA-42D2-9C01-03A7BC783211Q34340482-009C3618-BAFA-4816-9997-7080C44C36F0Q34421574-BD36B59B-114B-4D11-8077-E4EEEAE8E32AQ34465900-A8D8C44D-7B05-4A17-8CC7-E3CE2D86FAB8Q34482124-CC2B2D5F-727C-4EF5-810B-DC7F8BD40D4FQ34577021-9C7EAC8E-98D3-4367-81F9-6D054D6F91E3Q35088175-5AD4590D-D0FE-49D5-A24D-6D9A034048BAQ35088241-6483810B-918F-419A-9940-E629B8D53C33Q35531658-0E8B77F9-B8EF-491A-B1AD-7BB0C9347F25Q35576931-6BD86AD1-EE17-435D-AD9A-8B4CC9A40796Q35634949-8BF53787-4A3F-4EDE-B3EF-C3E330407873Q35821221-12B0B698-948A-4244-B984-048F82A98386Q35835376-C5AE6C36-7E8A-499E-91B7-F8FA49040311Q36042649-E388FC70-B675-4745-BCCD-82C11DB3F69DQ36065802-48F0976A-61C5-478E-B159-0E1E8E83A190Q36225155-4B94E8C4-F185-42F2-A3EF-7E27205E1350Q36455241-75276C82-A8A0-4E0B-B877-5B7E62BD3EE7Q36483688-D8E53E3D-B666-487A-B0F9-A73D60DEC07FQ36960167-393E5F32-4BAD-4E7E-9F98-071D30AA9149Q37092673-702474CB-B834-45F0-9B26-D1B04E939B98Q37187543-DA8FE1F3-33C1-4E7B-96BF-527694A94DD4Q37247915-6668B5D2-8852-4BE4-947A-109977796EADQ37278032-F62530E2-1177-4808-8015-C983501C681BQ37354906-243D3F8F-D89E-4B24-B0A4-DDBC9027B143
P2860
Immunoproteasomes largely replace constitutive proteasomes during an antiviral and antibacterial immune response in the liver.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Immunoproteasomes largely repl ...... immune response in the liver.
@en
Immunoproteasomes largely repl ...... immune response in the liver.
@nl
type
label
Immunoproteasomes largely repl ...... immune response in the liver.
@en
Immunoproteasomes largely repl ...... immune response in the liver.
@nl
prefLabel
Immunoproteasomes largely repl ...... immune response in the liver.
@en
Immunoproteasomes largely repl ...... immune response in the liver.
@nl
P2093
P1476
Immunoproteasomes largely repl ...... immune response in the liver.
@en
P2093
Groettrup M
de Giuli R
van den Broek M
P304
P356
10.4049/JIMMUNOL.167.12.6859
P407
P577
2001-12-01T00:00:00Z